Steven Petak, MD
NPI 1861493157 · Endocrinology, Diabetes & Metabolism Physician · Houston, TX
Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Steven Petak, MD is a Endocrinology, Diabetes & Metabolism Physician provider in Houston, TX (NPI 1861493157).
Provider details
- NPI number
- 1861493157
- Entity type
- Individual
- Primary specialty
- Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- G1147 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
20 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Levothyroxine Sodium | 141 | 71 |
| Alendronate Sodium | 116 | 61 |
| Raloxifene Hcl | 69 | 32 |
| Abaloparatidebrand: Tymlos | 49 | — |
| Levothyroxine Sodiumbrand: Synthroid | 45 | 26 |
| Methimazole | 20 | — |
| Teriparatide | 14 | — |
These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$111,924 across 171 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-08-09
- Last updated
- 2014-08-13
Frequently asked questions
- What is Steven Petak's NPI number?
- Steven Petak's National Provider Identifier (NPI) is 1861493157, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Steven Petak's specialty?
- Steven Petak is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
- Where is Steven Petak located?
- Steven Petak's practice location on file with NPPES is 6550 Fannin St, Houston, TX 77030-2717.
- What is Steven Petak's phone number?
- The practice phone number listed in the NPPES registry for Steven Petak is (713) 441-0006.
- Does Steven Petak accept Medicare?
- Steven Petak is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Steven Petak's NPI active?
- Yes — Steven Petak's NPI (1861493157) is active in the NPPES registry as of the last update on 2014-08-13.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.